KRAS MUTATION, CODON 12 & 13 FRAGMENT ANALYSIS

  • Test Usage:
    KRAS mutation testing is recommended prior to initiation of EGFR targeted therapy in Colorectal carcinoma. Absence of detectable KRAS mutation within the tumor suggests that this patient may respond to such therapies.
  • Report Availability:
    Sample by Tue 11 am; Report Mon
  • Sample Report:
215 Diagnostic Centers found for KRAS MUTATION, CODON 12 & 13 FRAGMENT ANALYSIS in Delhi